H.Res. 1274 · 117th Congress

Of inquiry directing the President to provide certain documents in the President's possession to the House of Representatives relating to communications by or among any of the Department of Health and Human Services, the Office of National Drug Control Policy, the White House, the Drug Enforcement Administration, and the Department of Justice related to the executive branch's recommendations for a long-term, consensus approach to reduce the supply and availability of illicitly manufactured fentanyl-related substances in the United States.

Stage
Reported from committee
Sponsor
Robert Latta
Introduced
2022-07-26
Latest action
2022-09-29 · Reported by the Committee on Energy and Commerce. H. Rept. 117-527.

Action history

  1. 2022-09-29Reported by the Committee on Energy and Commerce. H. Rept. 117-527.
  2. 2022-09-29Placed on the House Calendar, Calendar No. 133.
  3. 2022-09-21Subcommittee on Health Discharged.
  4. 2022-09-21Committee Consideration and Mark-up Session Held.
  5. 2022-09-21Ordered to be Reported Without Recommendation by the Yeas and Nays: 32 - 22.
  6. 2022-07-27Referred to the Subcommittee on Health.
  7. 2022-07-26Introduced in House
  8. 2022-07-26Referred to the House Committee on Energy and Commerce.